Inhibitory effect of quercetin on primary ovarian and endometrial cancers and synergistic activity with cis-diamminedichloroplatinum (II).
Scambia
G
G
Ranelletti
F O
FO
Benedetti Panici
P
P
Piantelli
M
M
Bonanno
G
G
De Vincenzo
R
R
Ferrandina
G
G
Maggiano
N
N
Capelli
A
A
Mancuso
S
S
D002471:Cell Transformation, Neoplastic / Q000187:drug effects / Q000473:pathology; D002945:Cisplatin / Q000592:standards / Q000627:therapeutic use*; D004357:Drug Synergism; D016889:Endometrial Neoplasms / Q000188:drug therapy* / Q000473:pathology; D005260:Female; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology; D011794:Quercetin / Q000592:standards / Q000627:therapeutic use*
D011794:Quercetin; D002945:Cisplatin